🚀 VC round data is live in beta, check it out!
Icecure Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Icecure Medical and similar public comparables like IMD International Medical, TELA Bio, Myomo, European Medical Solutions and more.
Icecure Medical Overview
About Icecure Medical
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Founded
2006
HQ
Employees
66
Website
Financials (LTM)
EV
$19M
Icecure Medical Financials
Icecure Medical reported last 12-month revenue of $5M.
In the same LTM period, Icecure Medical generated $2M in gross profit and had net loss of ($15M).
Revenue (LTM)
Icecure Medical P&L
In the most recent fiscal year, Icecure Medical reported revenue of $3M and EBITDA of ($15M).
Icecure Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $5M | XXX | $3M | XXX | XXX | XXX |
| Gross Profit | $2M | XXX | $1M | XXX | XXX | XXX |
| Gross Margin | 43% | XXX | 36% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($15M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (438%) | XXX | XXX | XXX |
| EBIT Margin | (329%) | XXX | (447%) | XXX | XXX | XXX |
| Net Profit | ($15M) | XXX | ($15M) | XXX | XXX | XXX |
| Net Margin | (326%) | XXX | (446%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Icecure Medical Stock Performance
Icecure Medical has current market cap of $28M, and enterprise value of $19M.
Market Cap Evolution
Icecure Medical's stock price is $0.34.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19M | $28M | 1.9% | XXX | XXX | XXX | $-0.19 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIcecure Medical Valuation Multiples
Icecure Medical trades at 4.2x EV/Revenue multiple, and (1.3x) EV/EBITDA.
EV / Revenue (LTM)
Icecure Medical Financial Valuation Multiples
As of April 11, 2026, Icecure Medical has market cap of $28M and EV of $19M.
Equity research analysts estimate Icecure Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Icecure Medical has a P/E ratio of (1.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $28M | XXX | $28M | XXX | XXX | XXX |
| EV (current) | $19M | XXX | $19M | XXX | XXX | XXX |
| EV/Revenue | 4.2x | XXX | 5.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (1.3x) | XXX | XXX | XXX |
| EV/EBIT | (1.3x) | XXX | (1.3x) | XXX | XXX | XXX |
| EV/Gross Profit | 9.6x | XXX | 15.7x | XXX | XXX | XXX |
| P/E | (1.9x) | XXX | (1.9x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (1.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Icecure Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Icecure Medical Margins & Growth Rates
Icecure Medical's revenue in the last 12 month grew by 107%.
Icecure Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Icecure Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 107% | XXX | 135% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (438%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (4%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 111% | XXX | 129% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 97% | XXX | 232% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 169% | XXX | 220% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 483% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Icecure Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| IMD International Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| TELA Bio | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| European Medical Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| CS Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Icecure Medical M&A Activity
Icecure Medical acquired XXX companies to date.
Last acquisition by Icecure Medical was on XXXXXXXX, XXXXX. Icecure Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Icecure Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialIcecure Medical Investment Activity
Icecure Medical invested in XXX companies to date.
Icecure Medical made its latest investment on XXXXXXXX, XXXXX. Icecure Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Icecure Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Icecure Medical
| When was Icecure Medical founded? | Icecure Medical was founded in 2006. |
| Where is Icecure Medical headquartered? | Icecure Medical is headquartered in United States. |
| How many employees does Icecure Medical have? | As of today, Icecure Medical has over 66 employees. |
| Who is the CEO of Icecure Medical? | Icecure Medical's CEO is Eyal Shamir. |
| Is Icecure Medical publicly listed? | Yes, Icecure Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Icecure Medical? | Icecure Medical trades under ICCM ticker. |
| When did Icecure Medical go public? | Icecure Medical went public in 2013. |
| Who are competitors of Icecure Medical? | Icecure Medical main competitors are IMD International Medical, TELA Bio, Myomo, European Medical Solutions. |
| What is the current market cap of Icecure Medical? | Icecure Medical's current market cap is $28M. |
| What is the current revenue of Icecure Medical? | Icecure Medical's last 12 months revenue is $5M. |
| What is the current revenue growth of Icecure Medical? | Icecure Medical revenue growth (NTM/LTM) is 107%. |
| What is the current EV/Revenue multiple of Icecure Medical? | Current revenue multiple of Icecure Medical is 4.2x. |
| Is Icecure Medical profitable? | No, Icecure Medical is not profitable. |
| What is the current net income of Icecure Medical? | Icecure Medical's last 12 months net income is ($15M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.